检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation.

Yifei Guo,Jiajia Han,Yongmei Zhang,Chengmeng Jin,Yao Zhang,Jingjing He,Shiqi Chen,Yue Guo,Yanxue Lin,Fahong Li,Feifei Yang,Zhongliang Shen,Richeng Mao,Haoxiang Zhu,Jiming Zhang

Frontiers in cellular and infection microbiology（2023）

引用 0|浏览11
暂无评分
摘要
EOT HBeAg negativity and anti-HBs ≥1.3 logIU/L identify the low risk of HRV after PEG-IFN discontinuation.
更多
查看译文
关键词
HBeAg,HBsAg reversion,PEG-IFN,anti-HBs,chronic hepatitis B,functional cure
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要